Immunic
IMUX13.0105.79% ( -0.800 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Immunic(IMUX) predict that the EBIT is -33.24 M (-23.9%), Miss estimate;the EPS is -1.08 (+56.8%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.03B23.90%
-0.03B3.97%
-0.01B27.87%
EPSMiss expectations
-1.0856.80%
-0.957161.71%
-0.12294.91%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf